KELHALE is a brand name for a medication primarily used in the management and treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains the active ingredient fluticasone furoate, which is a type of corticosteroid. Corticosteroids work by reducing inflammation in the airways, making it easier for patients to breathe. KELHALE is administered through an inhaler device, allowing the medication to be delivered directly into the lungs. It is often prescribed as a maintenance treatment to prevent and control symptoms such as wheezing, shortness of breath, and persistent coughing, rather than for immediate relief of acute symptoms. Patients are advised to use KELHALE regularly to achieve the best results, and not as a rescue inhaler for sudden breathing problems.